Morphological and Quantitative Parametric MRI Follow-up of Cartilage Changes Before and After Intra-articular Injection Therapy in Patients With Mild to Moderate Knee Osteoarthritis. A Randomized, Placebo-Controlled Trial
In brief
This placebo-controlled randomised trial used detailed MRI mapping to look at knee cartilage after an injection of steroid, hyaluronic acid or platelet-rich plasma (PRP) in mild to moderate osteoarthritis. The authors report a favourable effect of PRP on cartilage quality in one area of the knee after about a year, but none of the injections beat placebo on structural cartilage measures.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Morphological and Quantitative Parametric MRI Follow-up of Cartilage Changes Before and After Intra-articular Injection Therapy in Patients With Mild to Moderate Knee Osteoarthritis. A Randomized, Placebo-Controlled Trial Authors: Tschopp, Marcel MD, OLY; Pfirrmann, Christian W.A. MD, MBA; Brunner, Florian MD, PhD; Fucentese, Sandro F. MD; Galley, Julien MD; Stern, Christoph MD; Sutter, Reto MD; Catanzaro, Sabrina; Kühne, Nathalie; Rosskopf, Andrea B. MD Link: https://journals.lww.com/investigativeradiology/fulltext/2024/09000/morphological_and_qua Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

